Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Feb 7, 2023; 29(5): 815-824
Published online Feb 7, 2023. doi: 10.3748/wjg.v29.i5.815
Published online Feb 7, 2023. doi: 10.3748/wjg.v29.i5.815
Outcomes of COVID-19 among patients with liver disease
Isidora Vujčić, Institute of Epidemiology, Faculty of Medicine, University of Belgrade, Belgrade 11000, Belgrade, Serbia
Author contributions: Isidora Vujcic wrote the manuscript and performed the literature search.
Conflict-of-interest statement: The author states there is no conflict of interest to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Isidora Vujčić, MD, PhD, Associate Professor, Institute of Epidemioisidora.vujcic@med.bg.ac.rs
Received: September 17, 2022
Peer-review started: September 17, 2022
First decision: November 15, 2022
Revised: December 25, 2022
Accepted: January 20, 2023
Article in press: January 20, 2023
Published online: February 7, 2023
Peer-review started: September 17, 2022
First decision: November 15, 2022
Revised: December 25, 2022
Accepted: January 20, 2023
Article in press: January 20, 2023
Published online: February 7, 2023
Core Tip
Core Tip: Drastic lifestyle changes during the coronavirus disease 2019 (COVID-19) pandemic have led to an increase in the incidence of liver disease. Liver damage in COVID-19 infection occurs during disease progression in patients with or without previous liver disorders and represents a risk factor for developing severe illness and death. The prognosis of COVID-19 infection depends predominantly on the patients’ characteristics, present comorbidities, severity of clinical symptoms, laboratory parameters, and imaging features. It is important to examine prognostic factors in COVID-19 disease patients with liver disease because it may improve the outcome.